{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:20:06Z","timestamp":1786972806696,"version":"build-2736575974"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CACMS Innovation Fund","award":["CI2023C006YG"],"award-info":[{"award-number":["CI2023C006YG"]}]},{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs","award":["ZG2024001-03"],"award-info":[{"award-number":["ZG2024001-03"]}]},{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs","award":["CI2024E003KC-11"],"award-info":[{"award-number":["CI2024E003KC-11"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["82192913"],"award-info":[{"award-number":["82192913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["82304861"],"award-info":[{"award-number":["82304861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundamental Research Funds for the Central public welfare research institutes","award":["ZXKT21018"],"award-info":[{"award-number":["ZXKT21018"]}]},{"name":"Fundamental Research Funds for the Central public welfare research institutes","award":["ZZ15-YQ-045"],"award-info":[{"award-number":["ZZ15-YQ-045"]}]},{"name":"Scientific and technological innovation project of China Academy of Chinese Medical Sciences","award":["CI2023E002-Y-42"],"award-info":[{"award-number":["CI2023E002-Y-42"]}]},{"name":"CACMS Foundation","award":["ZZ15-YQ-046"],"award-info":[{"award-number":["ZZ15-YQ-046"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Xiebai San (XBS), a classical Traditional Chinese Medicine formula comprising Cortex mori, Lycii Radicis Cortex, and Glycyrrhizae Radix et Rhizoma, has long been used for pulmonary inflammatory disorders. However, its underlying mechanisms remain un-clear. This study aimed to investigate the mechanisms by which XBS alleviates allergic pulmonary inflammation. Methods: Two murine models were established, consisting of a chronic ovalbumin (OVA)-induced model simulating adaptive immune responses and an acute compound 48\/80-induced model triggering non-IgE-dependent mast cell activation. Pharmacodynamic indices including serum IgE, histamine, inflammatory cytokines, leukocyte profiles, and lung histopathology were evaluated. Network pharmacology was employed to predict core pathways. Arachidonic acid metabolites (AAMs) in lung tissues were quantified by targeted UPLC-MS\/MS, and p38 MAPK signaling proteins were assessed by Western blot. Results: XBS significantly alleviated lung injury in both models. In the chronic OVA-induced model, XBS significantly reduced serum immunoglobulin E levels and inflammatory cell infiltration. In the acute model, XBS suppressed histamine release and mast cell-mediated inflammatory responses. Targeted metabolomics revealed differential regulatory mechanisms: XBS reduced lipoxygenase-derived metabolites, including leukotrienes and 12-hydroxyeicosatetraenoic acid in chronic inflammation, while suppressing cyclooxygenase-related prostaglandins in acute inflammation. Network pharmacology analysis identified arachidonic acid (AA) metabolism as a potential central pathway. The p38 mitogen-activated protein kinase pathway was partially involved. Conclusions: XBS effectively alleviates both chronic and acute allergic pulmonary inflammation through differential modulation of AA metabolism, providing mechanistic insights supporting its traditional use in allergic airway diseases.<\/jats:p>","DOI":"10.3390\/ph19030440","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:27:18Z","timestamp":1773062838000},"page":"440","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Xiebai San Alleviates Allergic Pulmonary Inflammation by Modulating Arachidonic Acid Metabolism"],"prefix":"10.3390","volume":"19","author":[{"given":"Xingnan","family":"Yue","sequence":"first","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Han","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Pan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-0421","authenticated-orcid":false,"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/ppul.27373","article-title":"Update in Asthma Management in Low-Middle Income Countries","volume":"60","author":"Lachner","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_2","unstructured":"GBD 2021 Asthma and Allergic Diseases Collaborators (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990\u20132021, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Respir. Med., 13, 425\u2013446."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/all.15807","article-title":"Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"78","author":"Shin","year":"2023","journal-title":"Allergy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103051","DOI":"10.1016\/j.eclinm.2024.103051","article-title":"Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: A systematic analysis of the global burden of disease study 2021","volume":"80","author":"Yuan","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1038\/ncomms14937","article-title":"Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma","volume":"8","author":"Verstraete","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119457","DOI":"10.1016\/j.jep.2025.119457","article-title":"Anti-inflammatory and immunomodulatory effects of Glycyrrhiza uralensis fisch. On ulcerative colitis in rats: Role of nucleotide-binding oligomerization domain 2\/receptor-interacting protein 2\/nuclear factor-kappa B signaling pathway","volume":"344","author":"Zhong","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: A review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"670814","DOI":"10.1155\/2014\/670814","article-title":"The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: Pilot study","volume":"2014","author":"Pniewska","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s13555-022-00737-7","article-title":"Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis","volume":"12","author":"Haddad","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112635","DOI":"10.1016\/j.jep.2020.112635","article-title":"Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas","volume":"252","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118609","DOI":"10.1016\/j.jep.2024.118609","article-title":"Elucidation of anti-pneumonia pharmacodynamic material basis and potential mechanisms of Xiebai San by combining spectrum-efficacy relationship and surface plasmon resonance","volume":"335","author":"Zhao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref_14","first-page":"4486","article-title":"Identification of compounds in Lycii Cortex by UPLC-LTQ-Orbitrap-MS","volume":"44","author":"Chen","year":"2019","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104803","DOI":"10.1016\/j.fitote.2020.104803","article-title":"Recent advances in chemical analysis of licorice (Gan-Cao)","volume":"149","author":"Cheng","year":"2021","journal-title":"Fitoterapia"},{"key":"ref_16","first-page":"2237","article-title":"Systematic analysis on chemical constituents of Mori Cortex, mulberry root bark and its phellem layer based on HPLC-ESI-MS","volume":"46","author":"Zheng","year":"2021","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155397","DOI":"10.1016\/j.phymed.2024.155397","article-title":"Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK\/Stat3 pathway and regulating multiple metabolisms","volume":"128","author":"Zhao","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Luo, Z., Huang, J., Li, E., He, X., Meng, Q., Huang, X., Shen, X., and Yan, C. (2022). An Integrated Pharmacology-Based Strategy to Investigate the Potential Mechanism of Xiebai San in Treating Pediatric Pneumonia. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.784729"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1039\/C3MB25605G","article-title":"Understanding traditional Chinese medicine anti-inflammatory herbal formulae by simulating their regulatory functions in the human arachidonic acid metabolic network","volume":"9","author":"Gu","year":"2013","journal-title":"Mol. Biosyst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/st9.0000000000000021","article-title":"Huashi Baidu formula alleviates lipopolysaccharide-induced inflammation and acute lung injury in mice by targeting nuclear factor \u03baB\/phosphatidylinositol 3-kinase and peroxiredoxin 5","volume":"2","author":"Shen","year":"2024","journal-title":"Sci. Tradit. Chin. Med."},{"key":"ref_21","first-page":"168","article-title":"Literature Research on Origin and Application of Classical Prescription Xiebaisan","volume":"27","author":"Liang","year":"2021","journal-title":"Chin. J. Exp. Tradit. Med. Form."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-4939-8994-2_28","article-title":"OVA-Induced Allergic Airway Inflammation Mouse Model","volume":"1916","author":"Casaro","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kim, D.I., Song, M.K., and Lee, K. (2019). Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes. BMC Pulm. Med., 19.","DOI":"10.1186\/s12890-019-1001-9"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41598-023-27897-6","article-title":"Compound 48\/80 increases murine bladder wall compliance independent of mast cells","volume":"13","author":"Saxena","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_25","first-page":"2660","article-title":"Research progress on chemical constituents and pharmacological effects of Glycyrrhizae Radix et Rhizoma and discussion of Q-markers","volume":"46","author":"Deng","year":"2021","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"ref_26","first-page":"1114","article-title":"Research progress on chemical constituents, pharmacology, and quality control of Mori Cortex","volume":"41","author":"Ding","year":"2021","journal-title":"Chin. J. Pharm. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jep.2009.05.007","article-title":"Xia-bai-san inhibits lipopolysaccharide-induced activation of intercellular adhesion molecule-1 and nuclear factor-kappa B in human lung cells","volume":"124","author":"Lee","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/bph.12062","article-title":"Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model","volume":"168","author":"Toledo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"L670","DOI":"10.1152\/ajplung.00465.2007","article-title":"Aerobic conditioning and allergic pulmonary inflammation in mice. II. Effects on lung vascular and parenchymal inflammation and remodeling","volume":"295","author":"Vieira","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hachim, M.Y., Alqutami, F., Hachim, I.Y., Al Heialy, S., Busch, H., Hamoudi, R., and Hamid, Q. (2022). The Role of Systems Biology in Deciphering Asthma Heterogeneity. Life, 12.","DOI":"10.3390\/life12101562"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jss.2009.01.009","article-title":"Lipoxin a(4) attenuates microvascular fluid leak during inflammation","volume":"156","author":"Ereso","year":"2009","journal-title":"J. Surg. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/jpet.109.159046","article-title":"Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation","volume":"332","author":"Kure","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","first-page":"226","article-title":"Effects of a Leukotriene receptor antagonist on airway remodeling in asthmatic mice via the Wnt\/\u03b2-catenin signaling pathway","volume":"47","author":"Jiang","year":"2018","journal-title":"J. China Med. Univ."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jo-Watanabe, A., Okuno, T., and Yokomizo, T. (2019). The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143580"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: Advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","article-title":"Transcellular biosynthesis of eicosanoids","volume":"62","author":"Sala","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2019-0325OC","article-title":"Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling","volume":"63","author":"Ueno","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lim\u00f3n, A., Joaquin, M., Caballero, M., Posas, F., and de Nadal, E. (2020). The p38 Pathway: From Biology to Cancer Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061913"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1194\/jlr.R057588","article-title":"Cytosolic phospholipase A2: Physiological function and role in disease","volume":"56","author":"Leslie","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R058701","article-title":"Calcium-independent phospholipases A2 and their roles in biological processes and diseases","volume":"56","author":"Ramanadham","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1074\/jbc.M407438200","article-title":"Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity","volume":"280","author":"Rubin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Moon, T.C., Befus, A.D., and Kulka, M. (2014). Mast cell mediators: Their differential release and the secretory pathways involved. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00569"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1568010053586354","article-title":"Arachidonic acid signaling in pathogenesis of allergy: Therapeutic implications","volume":"4","author":"Closa","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/1673-5374.346460","article-title":"Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0092-8674(00)80744-8","article-title":"Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism","volume":"97","author":"Dessen","year":"1999","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1471-4159.2002.01145.x","article-title":"Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes","volume":"83","author":"Xu","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Han, J., Pan, C., Tang, X., Li, Q., Zhu, Y., Zhang, Y., and Liang, A. (2022). Hypersensitivity reactions to small molecule drugs. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1016730"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2021.02.012","article-title":"Non-IgE-mediated anaphylaxis","volume":"147","author":"Cianferoni","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Moya-Garc\u00eda, A.A., Pino-\u00c1ngeles, A., S\u00e1nchez-Jim\u00e9nez, F., Urdiales, J.L., and Medina, M. (2021). Histamine, Metabolic Remodelling and Angiogenesis: A Systems Level Approach. Biomolecules, 11.","DOI":"10.3390\/biom11030415"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"114152","DOI":"10.1016\/j.biopha.2022.114152","article-title":"IRGM\/Irgm1 deficiency inhibits neutrophil-platelet interactions and thrombosis in experimental atherosclerosis and arterial injury","volume":"158","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: An update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2007.01.001","article-title":"Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation","volume":"46","author":"Kang","year":"2007","journal-title":"Prog. Lipid Res."},{"key":"ref_54","first-page":"2452","article-title":"Changes in miRNA expressions in the injured small intestine of mice following high-dose radiation exposure","volume":"21","author":"Chiba","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12967-021-03036-5","article-title":"Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling","volume":"19","author":"Cheng","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102010","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12931-017-0697-4","article-title":"Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model","volume":"18","author":"Bao","year":"2017","journal-title":"Respir. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Orsini, E.M., Perelas, A., Southern, B.D., Grove, L.M., Olman, M.A., and Scheraga, R.G. (2021). Stretching the Function of Innate Immune Cells. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.767319"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.4049\/jimmunol.0903035","article-title":"Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury","volume":"184","author":"Schingnitz","year":"2010","journal-title":"J. Immunol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/3\/440\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:16:55Z","timestamp":1773206215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/3\/440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ph19030440"],"URL":"https:\/\/doi.org\/10.3390\/ph19030440","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}